Zimmer Biomet Holdings, Inc.’s Registered Notes Offering

Cravath represented the underwriters in connection with the $500 million registered notes offering of Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare. The transaction closed on December 1, 2023.

The Cravath team included partners William V. Fogg and Michael E. Mariani and associate Nicolas Thomson on capital markets matters, partner Arvind Ravichandran and associate Clayton Hackney on tax matters, and partner Matthew Morreale on environmental matters. Mitchell Siegel also worked on capital markets matters and Eduardo D. Jacobo‑Arill also worked on tax matters.